Dr. Torous is with the Department of Psychiatry, Division of Digital Psychiatry, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston. Dr. Haim is with the Division of Division of Services and Intervention Research, National Institute of Mental Health, Bethesda, Maryland.
Psychiatr Serv. 2018 Dec 1;69(12):1204-1206. doi: 10.1176/appi.ps.201800193. Epub 2018 Sep 26.
The uptake and clinical adoption of digital mental health tools, such as smartphone apps, remain limited. Although some technology barriers remain, the greatest challenges are no longer technical. Instead, dichotomous directions and efforts divide the space and limit the potential of digital tools. This column focuses on six of these dichotomies, including randomized trials versus pragmatic studies, precision medicine versus population health, free market versus regulation, consumer versus clinical uses, big data versus privacy, and open versus proprietary software. Because no panacea exists, the authors suggest a more flexible approach to the uptake and clinical adoption of digital mental health tools-an approach that offers a pragmatic solution to better appreciate the landscape and pave the way toward progress.
数字心理健康工具(如智能手机应用程序)的采用仍然有限。尽管仍然存在一些技术障碍,但最大的挑战不再是技术问题。相反,二元化的方向和努力分割了空间,限制了数字工具的潜力。本专栏重点介绍了其中的六个二分法,包括随机试验与实用研究、精准医学与人群健康、自由市场与监管、消费者与临床用途、大数据与隐私以及开源与专有软件。由于没有灵丹妙药,作者建议采取更加灵活的方法来采用和临床应用数字心理健康工具——这种方法提供了一种实用的解决方案,可以更好地了解现状并为取得进展铺平道路。